Therapeutics
Pharmacological treatment for hyperlipidemia requires a combination of therapeutic lifestyle changes both in primary and secondary prevention ( Sawada et al., 2016). For the case of the patient with a history of hypertension and, therefore at a higher risk, statin therapy can be used as the best intervention to treat hyperlipidemia. Statins are backed with sufficient conniving data for the treatment of hyperlipidemia for higher-risk patients both in primary and secondary prevention ( Chuang et al., 2014 ). There are at least six statin drugs that are available for the treatment of this condition, and all these can be prescribed for the patient.
Educational
Statins can sometimes come with severe side effects, and the patient needs education on how to take the medication and manage the side effects. Research by American Heart Association shows that most people stop taking statin medication due to side effects and lack of education on how to manage such effects ( Taylor & Thompson, 2015 ). Also, the patient needs to be educated on the need for healthy diet by avoiding high-fat content foods ad instead take more proteins. These will help lower the rate of cholesterol and minimize the risks of cardiovascular conditions during medication. The patient should also be advised to be visiting the health center for more checkups during the medication period to determine if the drugs are effective.
Delegate your assignment to our experts and they will do the rest.
Collaboration
The patient should be placed in advanced care planning with constant communication and interaction with the care provider. Constant communication and monitoring of the progress of the patient are required to ensure that the patient is well informed on how to best manage the situation ( Azad & Mielniczuk , 2016). While under the care, the patient can be referred to a dietitian to help determine the best diet combination for the patient.
References
Azad, N. A., & Mielniczuk, L. (2016). A call for collaboration: improving cardiogeriatric care. Canadian Journal of Cardiology , 32 (9), 1041-1044.
Chuang, C. S., Yang, T. Y., Muo, C. H., Su, H. L., Sung, F. C., & Kao, C. H. (2014). Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study. General hospital psychiatry , 36 (5), 497-501.
Sawada, T., Tsubata, H., Hashimoto, N., Takabe, M., Miyata, T., Aoki, K., ... & Tsukishiro, Y. (2016). Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open-label, single-blinded, prospective randomized controlled trial. Cardiovascular diabetology , 15 (1), 121.
Taylor, B. A., & Thompson, P. D. (2015). Muscle-related side-effects of statins: from mechanisms to evidence-based solutions. Current opinion in lipidology , 26 (3), 221-227.
